Viewing Study NCT00306267

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-04-13 @ 8:15 AM
Study NCT ID: NCT00306267
Status: TERMINATED
Last Update Posted: 2011-05-18
First Post: 2006-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia View
None Cancer View
None Epoetin Alfa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anemia View
None non-chemotherapy-induced View
None non-radiation therapy-induced View
None cancer View
None non-myeloid View